Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

Launched by UNIVERSITY OF PRETORIA · Nov 3, 2016

Keywords

ClinConnect Summary

This clinical trial is focused on improving the screening and prevention of cervical cancer in South African women. Cervical cancer is a significant health issue in South Africa, with nearly 8,000 new cases diagnosed each year. The study aims to test a new screening method that uses a human papillomavirus (HPV) test, which is thought to be more effective than the traditional cytology test (which looks for cell changes). The researchers believe that using the HPV test followed by additional checks will help find more cases of pre-cancerous conditions and reduce the number of women who develop cervical cancer.

To participate in the trial, women aged 18 to 65 who are seeking cervical cancer screening are eligible, as long as they are not pregnant, have not had a hysterectomy, and have not received treatment for any gynecological cancer. Participants will need to provide informed consent and will receive their test results via text message or during a clinic visit. This study is crucial for understanding how well the new HPV screening works, especially in women who may be at higher risk due to factors like HIV infection.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Informed consent accepted and signed
• • Health seeking behaviour or request for a cervical cancer screening test
• • Willing and able to receive test result by automated text message or clinic visit
• Exclusion Criteria:
• • Current pregnancy
• • Hysterectomy
• • Current or previous treatment for gynaecological cancer
• • Hesitant or unable to undergo screening and treatment if indicated